|
1
|
Libby P, Lichtman AH and Hansson GK:
Immune effector mechanisms implicated in atherosclerosis: From mice
to humans. Immunity. 38:1092–1104. 2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kwon GP, Schroeder JL, Amar MJ, Remaley AT
and Balaban RS: Contribution of macromolecular structure to the
retention of low-density lipoprotein at arterial branch points.
Circulation. 117:2919–2927. 2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bäck M and Hansson GK: Anti-inflammatory
therapies for atherosclerosis. Nat Rev Cardiol. 12:199–211.
2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Herrero-Fernandez B, Gomez-Bris R,
Somovilla-Crespo B and Gonzalez-Granado JM: Immunobiology of
atherosclerosis: A complex net of interactions. Int J Mol Sci.
20(5293)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gimbrone MA Jr and García-Cardeña G:
Endothelial cell dysfunction and the pathobiology of
atherosclerosis. Circ Res. 118:620–636. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Barrett TJ: Macrophages in atherosclerosis
regression. Arterioscler Thromb Vasc Biol. 40:20–33.
2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chistiakov DA, Orekhov AN and Bobryshev
YV: Endothelial barrier and its abnormalities in cardiovascular
disease. Front Physiol. 6(365)2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chistiakov DA, Melnichenko AA, Myasoedova
VA, Grechko AV and Orekhov AN: Mechanisms of foam cell formation in
atherosclerosis. J Mol Med (Berl). 95:1153–1165. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bakogiannis C, Sachse M, Stamatelopoulos K
and Stellos K: Platelet-derived chemokines in inflammation and
atherosclerosis. Cytokine. 122(154157)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Iademarco MF, Barks JL and Dean DC:
Regulation of vascular cell adhesion molecule-1 expression by IL-4
and TNF-alpha in cultured endothelial cells. J Clin Invest.
95:264–271. 1995.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Cantile M, Schiavo G, Terracciano L and
Cillo C: Homeobox genes in normal and abnormal vasculogenesis. Nutr
Metab Cardiovasc Dis. 18:651–658. 2008.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Duboule D and Morata G: Colinearity and
functional hierarchy among genes of the homeotic complexes. Trends
Genet. 10:358–364. 1994.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Gorski DH and Walsh K: The role of
homeobox genes in vascular remodeling and angiogenesis. Circ Res.
87:865–872. 2000.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bandyopadhyay S, Ashraf MZ, Daher P, Howe
PH and DiCorleto PE: HOXA9 participates in the transcriptional
activation of E-selectin in endothelial cells. Mol Cell Biol.
27:4207–4216. 2007.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pang J, Xu Q, Xu X, Yin H, Xu R, Guo S,
Hao W, Wang L, Chen C and Cao JM: Hexarelin suppresses high lipid
diet and vitamin D3-induced atherosclerosis in the rat. Peptides.
31:630–638. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zheng X and Hu X: Effects of rosuvastatin
on hypertension with carotid atherosclerosis and its influence on
peripheral macrophage polarization. Chinese Journal of Clinical
Pharmacology and Therapeutics. 22:1035–1039. 2017.
|
|
17
|
Wang J, Hou J, Lin C, Fu J, Ren J, Li L,
Guo H, Han X, Wang B and Liu J: Shuangshen ningxin capsule, a
traditional Chinese medicinal preparation, alleviates myocardial
ischemia through autophagy regulation. Evid Based Complement
Alternat Med. 2015(581260)2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Xu B, Geerts D, Bu Z, Ai J, Jin L, Li Y,
Zhang H and Zhu G: Regulation of endometrial receptivity by the
highly expressed HOXA9, HOXA11 and HOXD10 HOX-class homeobox genes.
Hum Reprod. 29:781–790. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sun X, He S, Wara AKM, Icli B, Shvartz E,
Tesmenitsky Y, Belkin N, Li D, Blackwell TS, Sukhova GK, et al:
Systemic delivery of microRNA-181b inhibits nuclear factor-κB
activation, vascular inflammation, and atherosclerosis in
apolipoprotein E-deficient mice. Circ Res. 114:32–40.
2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Shirai T, Hilhorst M, Harrison DG, Goronzy
JJ and Weyand CM: Macrophages in vascular inflammation-From
atherosclerosis to vasculitis. Autoimmunity. 48:139–151.
2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Nitsa A, Toutouza M, Machairas N, Mariolis
A, Philippou A and Koutsilieris M: Vitamin D in cardiovascular
disease. In Vivo. 32:977–981. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Xie W, Li L, Zhang M, Cheng HP, Gong D, Lv
YC, Yao F, He PP, Ouyang XP, Lan G, et al: MicroRNA-27 prevents
atherosclerosis by suppressing lipoprotein lipase-induced lipid
accumulation and inflammatory response in apolipoprotein E knockout
mice. PLoS One. 11(e0157085)2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Calvo KR, Sykes DB, Pasillas M and Kamps
MP: Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating
factor-dependent promyelocyte capable of biphenotypic
differentiation to neutrophils or macrophages, independent of
enforced meis expression. Mol Cell Biol. 20:3274–3285.
2000.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Trivedi CM, Patel RC and Patel CV:
Homeobox gene HOXA9 inhibits nuclear factor-kappa B dependent
activation of endothelium. Atherosclerosis. 195:e50–e60.
2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Xuan W, Qu Q, Zheng B, Xiong S and Fan GH:
The chemotaxis of M1 and M2 macrophages is regulated by different
chemokines. J Leukoc Biol. 97:61–69. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Li W, Tang C, Jin H and Du J: Effects of
onion extract on endogenous vascular H2S and adrenomedulin in rat
atherosclerosis. Curr Pharm Biotechnol. 12:1427–1439.
2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Domschke G and Gleissner CA: CXCL4-induced
macrophages in human atherosclerosis. Cytokine.
122(154141)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Jiang Y, Jiang LL, Maimaitirexiati XM,
Zhang Y and Wu L: Irbesartan attenuates TNF-α-induced ICAM-1,
VCAM-1, and E-selectin expression through suppression of NF-κB
pathway in HUVECs. Eur Rev Med Pharmacol Sci. 19:3295–3302.
2015.PubMed/NCBI
|
|
29
|
Shih MF, Pan KH, Liu CC, Shen CR and
Cherng JY: Treatment of β-thujaplicin counteracts
di(2-ethylhexyl)phthalate (DEHP)-exposed vascular smooth muscle
activation, inflammation and atherosclerosis progression. Regul
Toxicol Pharmacol. 92:333–337. 2018.PubMed/NCBI View Article : Google Scholar
|
